摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(Methylthio)oxazolo<5,4-b>pyridine | 169205-97-4

中文名称
——
中文别名
——
英文名称
2-(Methylthio)oxazolo<5,4-b>pyridine
英文别名
2-(methylthio)oxazolo[5,4-b]pyridine;2-(methylthio)[1,3]oxazolo[5,4-b]pyridine;2-methylsulfanyl-[1,3]oxazolo[5,4-b]pyridine
2-(Methylthio)oxazolo<5,4-b>pyridine化学式
CAS
169205-97-4
化学式
C7H6N2OS
mdl
——
分子量
166.203
InChiKey
DKBGQXNLKVPGPF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    64.2
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-(Methylthio)oxazolo<5,4-b>pyridine 生成 4-(oxazolo[5,4-b]pyridin-2-yl)-1,4-diaza-bicyclo[3.2.2]nonane
    参考文献:
    名称:
    Pharmaceutical composition for the treatment of CNS and other disorders
    摘要:
    本发明涉及一种治疗哺乳动物中枢神经系统(CNS)和其他疾病的方法,包括人类,在哺乳动物中给予一种穿透中枢神经系统的α7烟碱受体激动剂。同时涉及含有药用可接受载体和穿透中枢神经系统的α7烟碱受体激动剂的药物组合物。
    公开号:
    US20020086871A1
  • 作为产物:
    描述:
    2-羟基-3-硝基吡啶 在 palladium on activated charcoal 氢气potassium carbonate 作用下, 以 四氢呋喃乙醇N,N-二甲基甲酰胺 为溶剂, 25.0 ℃ 、344.73 kPa 条件下, 反应 3.0h, 生成 2-(Methylthio)oxazolo<5,4-b>pyridine
    参考文献:
    名称:
    Preparation of the Four Regioisomeric 2-(Methylthio)oxazolopyridines: Useful Synthons for Elaboration to 2-(Amino substituted)oxazolopyridines
    摘要:
    DOI:
    10.1021/jo00122a073
点击查看最新优质反应信息

文献信息

  • MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES
    申请人:LIFE TECHNOLOGIES CORPORATION
    公开号:US20150218380A1
    公开(公告)日:2015-08-06
    Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance, and their uses, are described. Conjugation through this position results in spectral properties that are uniformly superior to those of conjugates of spectrally similar dyes wherein attachment is at a different position. The invention includes derivative compounds having one or more benzo nitrogens.
    化学反应性碳氰染料包含一个在3位被反应性基团或共轭物质取代的吲哚环部分,并描述了它们的用途。通过这个位置的共轭导致光谱特性均优于在不同位置附着的光谱相似染料的共轭物。该发明包括具有一个或多个苯并氮的衍生化合物。
  • Modified carbocyanine dyes and their conjugates
    申请人:MOLECULAR PROBES, INC.
    公开号:US20020077487A1
    公开(公告)日:2002-06-20
    Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance, and their uses, are described. Conjugation through this position results in spectral properties that are uniformly superior to those of conjugates of spectrally similar dyes wherein attachment is at a different position. The invention includes derivative compounds having one or more benzo nitrogens.
    描述了化学反应性碳氰染料,其中包含一个在3位被反应性基团或共轭物质取代的吲哚环部分,并描述了它们的用途。通过这个位置的共轭导致了光谱性质优于在不同位置附着的光谱相似染料的共轭物。该发明包括具有一个或多个苯并氮的衍生化合物。
  • Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists
    作者:Krzysztof Walczyński、Obbe P. Zuiderveld、Henk Timmerman
    DOI:10.1016/j.ejmech.2004.09.010
    日期:2005.1
    electrically evoked contraction of the guinea-pig jejunum). It appeared that by comparison of homologous pairs the thiazolo derivatives have slightly higher activity than their oxazolo analogues. The most potent compound of these series is the 1-(2-thiazolo[4,5-c]pyridine)-4-n-propylpiperazine (3c) with pA2 = 7.25 (its oxazole analogue (4g) showed pA2 = 6.9). The structure-activity relationships for compounds
    为了寻找新的非咪唑组胺H3受体拮抗剂,一系列的1 [((2-噻唑并吡啶)-4-正丙基]哌嗪,类似的1-[((2-恶唑并吡啶)-4-正丙基]]制备了哌嗪,1-[((2-苯并噻唑)-4-正丙基]哌嗪和1-[((2-苯并恶唑)4-正丙基]哌嗪,并在体外对其作为H3受体拮抗剂进行了测试(电诱发的收缩)豚鼠空肠)。通过比较同源对,噻唑洛衍生物似乎比它们的恶唑类似物具有更高的活性。这些系列中最有效的化合物是1-(2-噻唑并[4,5-c]吡啶)-4-正丙基哌嗪(3c),pA2 = 7.25(其恶唑类似物(4g)显示pA2 = 6.9)。
  • Intermediates and the synthesis of modified carbocyanine dyes and their conjugates
    申请人:Leung Wai-Yee
    公开号:US20060004188A1
    公开(公告)日:2006-01-05
    Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance, and their uses, are described. Conjugation through this position results in spectral properties that are uniformly superior to those of conjugates of spectrally similar dyes wherein attachment is at a different position. The invention includes derivative compounds having one or more benzo nitrogens.
    本发明涉及一种化学反应性碳氰染料,其包含一种在3位被反应性基团或共轭物质取代的吲哚环基团,并描述了其用途。通过此位置的共轭作用,其光谱特性比在不同位置附着的光谱类似染料的共轭体均匀优越。该发明包括具有一个或多个苯并氮原子的衍生物化合物。
  • Aza-benzazolium containing cyanine dyes
    申请人:——
    公开号:US20040137475A1
    公开(公告)日:2004-07-15
    Unsymmetrical cyanine dyes that incorporate an aza-benzazolium ring moiety are described, including cyanine dyes substituted by a cationic side chain, monomeric and dimeric cyanine dyes, chemically reactive cyanine dyes, and conjugates of cyanine dyes. The subject dyes are virtually non-fluorescent when diluted in aqueous solution, but exhibit bright fluorescence when associated with nucleic acid polymers such as DNA or RNA, or when associated with detergent-complexed proteins. A variety of applications are described for detection and quantitation of nucleic acids and detergent-complexed proteins in a variety of samples, including solutions, electrophoretic gels, cells, and microorganisms.
    描述了一种包含氮杂苯并咪唑环基团的不对称靛烷染料,包括带有阳离子侧链的靛烷染料,单体和二聚靛烷染料,化学反应性靛烷染料以及靛烷染料的共轭物。这些染料在水溶液中稀释时几乎不发荧光,但与核酸聚合物(如DNA或RNA)或与复合物化的蛋白质相结合时,会表现出明亮的荧光。描述了用于检测和定量各种样品中的核酸和复合物化蛋白质的各种应用,包括溶液、电泳凝胶、细胞和微生物。
查看更多

同类化合物

甲基吡噁磷 甲基吡啶磷-d6 恶唑并[5,4-B]吡啶-2-胺二盐酸盐 恶唑并[5,4-B]吡啶-2-胺 恶唑并[5,4-B]吡啶-2(1H)-硫酮 恶唑并[4,5-B]吡啶-2(3H)硫酮 噁唑并[5,4-c]吡啶-2-胺 噁唑并[5,4-c]吡啶-2(1h)-酮 噁唑并[5,4-b]吡啶-2(1h)-酮 噁唑并[5,4-b]吡啶 噁唑并[4,5-c]吡啶-2-胺 噁唑并[4,5-b]吡啶-2-胺 噁唑并[4,5-b]吡啶-2-羧酸乙酯 噁唑并[4,5-b]吡啶-2(3H)-酮,6-溴-3-(苯基甲基)- 噁唑并[4,5-b]吡啶-2(3H)-酮,6-乙酰基-3-[2-(2-吡啶基)乙基]- 噁唑并[4,5-b]吡啶-2(3H)-酮,3-(2-羰基丙基)- 噁唑并[4,5-b]吡啶,2-(1-甲基乙基)-(9CI) 噁唑并[4,5-b]吡啶 噁唑并[4,5-C]吡啶-2(3H)-硫酮 噁唑并[4,5-C]吡啶 [1,3]恶唑并[4,5-c]吡啶-6-羧酸 7-溴恶唑并[4,5-C]吡啶 7-溴-2-甲基-F唑并[4,5-C]吡啶 7-溴-2-乙基恶唑并[4,5-C]吡啶 6-溴恶唑并[5,4-B]吡啶-2-胺 6-溴恶唑并[5,4-B]吡啶 6-溴噁唑并[4,5-b]吡啶 6-溴-3H-恶唑并[4,5-b]吡啶-2-酮 6-溴-2-甲基噁唑并[5,4-b]吡啶 6-溴-2-甲基噁唑并[4,5-B]吡啶 6-溴-2-(三氟甲基)噁唑并[5,4-B]吡啶 6-溴-2-(三氟甲基)噁唑并[4,5-b]吡啶 6-氯恶唑并[4,5-b]吡啶-2(3H)-酮 5-甲基噁唑并[4,5-b]吡啶-2(3h)-酮 5-甲基-3H-恶唑并[4,5-B]吡啶-2-硫酮 5-溴-3H-恶唑并[4,5-b]吡啶-2-酮 3-[2-(4-氯苯基)乙基]-2-苯基亚氨基-1,3-噻唑烷-4-酮 3-(2-溴乙基)恶唑并[4,5-b]吡啶-2(3H)-酮 3-(2-吗啉-4-基乙基)[1,3]噁唑并[4,5-b]吡啶-2(3H)-酮 2-甲硫基唑并[4,5-B]吡啶 2-甲基硫基 [ 1,3 ] 恶唑酮[5,4-C]吡啶 2-甲基噁唑并[5,4-c]吡啶 2-甲基噁唑并[5,4-b]吡啶 2-甲基吡啶并噁唑 2-甲基[1,3]噁唑并[4,5-b]吡啶 2-氯甲基噁唑并[4,5-b]吡啶 2-氯恶唑并[5,4-b]吡啶 2-氯恶唑并[5,4-C]吡啶盐酸盐 2-氯恶唑并[5,4-C]吡啶 2-氯噁唑并[4,5-B]吡啶